ImmunoGen appoints Lauren White as SVP and CFO effective Sept. 18, 2023

ImmunoGen, Inc.

White previously served as CFO of C4 Therapeutics and VP at Novartis, with over 20 years experience.
Annual salary of $500,000 with bonus eligibility up to 40% of base salary.
Granted option for 295,975 shares and 51,625 RSUs under 2019 Inducement Plan.
Renee Lentini steps down as principal financial officer but remains principal accounting officer.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Renee Lentini

Vice President, Finance and Chief Accounting Officer

ImmunoGen, Inc.

Effective: 2023-09-18
Successor: Lauren White
Filed: September 18, 2023, 7:59 PM ET

Effective September 18, 2023, Renee Lentini, the Company’s Vice President, Finance and Chief Accounting Officer, ceased to be the Company’s principal financial officer but will continue in her role as principal accounting officer.

Appointed

Lauren White

Senior Vice President and Chief Financial Officer

ImmunoGen, Inc.

Effective: 2023-09-18
Filed: September 18, 2023, 7:59 PM ET

Effective September 18, 2023, ImmunoGen, Inc. (the “Company”) appointed Lauren White as Senior Vice President and Chief Financial Officer and designated her as the Company’s principal financial officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Renee Lentini changed role as Vice President, Finance and Chief Accounting Officer at ImmunoGen, Inc..

Action: ceased to be principal financial officer
Role: Vice President, Finance and Chief Accounting Officer

Exact text from the filing

Effective September 18, 2023, Renee Lentini, the Company’s Vice President, Finance and Chief Accounting Officer, ceased to be the Company’s principal financial officer but will continue in her role as principal accounting officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Lauren White was appointed as Senior Vice President and Chief Financial Officer at ImmunoGen, Inc..

Action: appointed
Role: Senior Vice President and Chief Financial Officer

Exact text from the filing

Effective September 18, 2023, ImmunoGen, Inc. (the “Company”) appointed Lauren White as Senior Vice President and Chief Financial Officer and designated her as the Company’s principal financial officer.

View on SEC.gov

Source: SEC EDGAR

accession 0001558370-23-015834

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.